Ad is loading...
ECDCX vs MEDAX
ECDCX vs MEDAX Comparison
Open Charts ECDCX vs MEDAX
Ashmore Emerging Mkts Corp Inc C
Price$5.41
Change+$0.03 (+0.56%)
VolumeN/A
Net Assets20.99M
MFS Emerging Markets Debt A
Price$11.83
Change+$0.07 (+0.60%)
VolumeN/A
Net Assets6.9B
ECDCX vs MEDAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
ECDCX vs. MEDAX commentary
Apr 24, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECDCX is a Sell and MEDAX is a Hold.
FUNDAMENTALS
Fundamentals
MEDAX has more cash in the bank: 6.9B vs. ECDCX (21M). MEDAX pays higher dividends than ECDCX: MEDAX (6.52) vs ECDCX (4.93). ECDCX was incepted earlier than MEDAX: ECDCX (14 years) vs MEDAX (27 years). ECDCX (2.20) is less costly to investors than MEDAX (1.07). ECDCX is a more actively managed with annual turnover of: 95.00 vs. MEDAX (58.00). ECDCX (1000) and MEDAX (1000) have matching initial minimum investment requirements. ECDCX annual gain was more profitable for investors over the last year : 6.51 vs. MEDAX (6.18). MEDAX return over 5 years is better than : 16.86 vs. ECDCX (8.01).
| ECDCX | MEDAX | ECDCX / MEDAX | |
| Total Expense Ratio | 1.87 | 1.06 | 176% |
| Annual Report Gross Expense Ratio | 2.20 | 1.07 | 206% |
| Fund Existence | 14 years | 27 years | - |
| Gain YTD | 0.103 | -0.192 | -54% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 21M | 6.9B | 0% |
| Annual Yield % from dividends | 4.93 | 6.52 | 76% |
| Returns for 1 year | 6.51 | 6.18 | 105% |
| Returns for 3 years | 3.04 | 13.09 | 23% |
| Returns for 5 years | 8.01 | 16.86 | 47% |
| Returns for 10 years | 15.47 | 28.47 | 54% |